Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-22 Sale |
2024-01-23 4:22 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
638 | $27.2 | $17,356 | 10,159 (Direct) |
View |
| 2023-11-15 Sale |
2023-11-16 7:24 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
20,000 | $22.53 | $450,646 | 1,296,497 (Indirect) |
View |
| 2023-10-20 Sale |
2023-10-25 09:38 am |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
564 | $17.06 | $9,623 | 8,760 (Direct) |
View |
| 2023-02-17 Sale(A) |
2023-10-20 6:37 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
1,076 | $19.06 | $20,509 | 18,842 (Direct) |
View |
| 2023-09-28 Sale |
2023-10-02 9:02 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
14,989 | $21.07 | $315,744 | 1,316,497 (Indirect) |
View |
| 2023-08-17 Sale |
2023-08-21 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
1,534 | $15.47 | $23,733 | 320,384 (Indirect Direct) |
View |
| 2023-08-17 Sale |
2023-08-21 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
4,767 | $15.47 | $73,750 | 931,092 (Indirect Direct) |
View |
| 2023-08-17 Sale |
2023-08-21 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
284 | $15.47 | $4,394 | 5,570 (Direct) |
View |
| 2023-07-20 Sale |
2023-07-24 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
573 | $19.03 | $10,906 | 7,129 (Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
4,122 | $21.38 | $88,108 | 927,880 (Indirect Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
1,330 | $21.38 | $28,429 | 317,929 (Indirect Direct) |
View |
| 2023-05-17 Sale |
2023-05-19 4:05 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
245 | $21.38 | $5,237 | 6,116 (Direct) |
View |
| 2023-04-21 Sale |
2023-04-25 6:33 pm |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
2,342 | $18.65 | $43,678 | 5,636 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-14 Exercise |
2024-02-16 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel |
9,712 | $0 | 29,079 (Direct) |
View |
| 2024-01-18 Exercise |
2024-01-22 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
1,586 | $0 | 18,729 (Direct) |
View |
| 2023-12-07 Option Award |
2023-12-12 8:51 pm |
N/A 2033-12-07 |
ROCKET PHARMACEUTICALS INC. | RCKT | Woods Keith Director |
32,482 | $0 | 32,482 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 7:17 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
3,989 | $0 | 347,656 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 7:09 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
7,979 | $0 | 978,969 (Direct) |
View |
| 2023-11-14 Exercise |
2023-11-16 6:58 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
725 | $0 | 13,113 (Direct) |
View |
| 2023-10-18 Exercise(A) |
2023-10-20 6:37 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
1,586 | $0 | 18,842 (Direct) |
View |
| 2023-10-05 Exercise |
2023-10-10 4:11 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
3,333 | $0 | 323,717 (Indirect) |
View |
| 2023-08-28 Other |
2023-08-30 4:15 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner |
500,000 | $22.05 | 20,157,605 (Indirect) |
View |
| 2023-08-28 Other |
2023-08-30 4:15 pm |
2018-08-27 2023-08-28 |
ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner |
2 | $0 | 20,157,605 (Indirect) |
View |
| 2023-08-28 Other |
2023-08-30 4:15 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner |
500,000 | $15.87 | 20,157,605 (Indirect) |
View |
| 2023-08-14 Exercise |
2023-08-15 4:17 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
725 | $0 | 12,207 (Direct) |
View |
| 2023-08-14 Exercise |
2023-08-15 4:16 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
3,989 | $0 | 345,911 (Direct) |
View |
| 2023-08-14 Exercise |
2023-08-15 4:06 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
7,979 | $0 | 983,736 (Direct) |
View |
| 2023-07-18 Exercise |
2023-07-20 4:05 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
1,586 | $0 | 18,806 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:48 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Yalamanchi Naveen Director |
25,850 | $0 | 25,850 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:48 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK Director 10% Owner |
3,590 | $13.93 | 29,440 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:48 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK Director 10% Owner |
25,850 | $0 | 29,440 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Malik Fady Ibraham Director |
25,850 | $0 | 25,850 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
2,872 | $13.93 | 28,722 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director |
25,850 | $0 | 28,722 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | BOESS CARSTEN Director |
25,850 | $0 | 25,850 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | GRANADILLO PEDRO P Director |
5,026 | $13.93 | 30,876 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | GRANADILLO PEDRO P Director |
25,850 | $0 | 30,876 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director |
3,590 | $13.93 | 29,440 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director |
25,850 | $0 | 29,440 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:47 pm |
N/A 2033-06-22 |
ROCKET PHARMACEUTICALS INC. | RCKT | SOUTHWELL DAVID P Director |
25,850 | $0 | 25,850 (Direct) |
View |
| 2023-05-14 Exercise |
2023-05-16 8:04 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO |
7,979 | $0 | 987,858 (Direct) |
View |
| 2023-05-14 Exercise |
2023-05-16 8:01 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
725 | $0 | 11,439 (Direct) |
View |
| 2023-05-14 Exercise |
2023-05-16 7:57 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks |
3,989 | $0 | 347,241 (Direct) |
View |
| 2023-04-18 Exercise |
2023-04-20 6:34 pm |
N/A N/A |
ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks |
6,364 | $0 | 20,648 (Direct) |
View |
| 2023-04-04 Option Award |
2023-04-12 7:00 pm |
N/A 2033-04-04 |
ROCKET PHARMACEUTICALS INC. | RCKT | White Mark Andrew Chief Medical Officer |
134,401 | $0 | 134,401 (Direct) |
View |